Compare AWF & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AWF | CRON |
|---|---|---|
| Founded | 1993 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 924.4M | 961.2M |
| IPO Year | N/A | N/A |
| Metric | AWF | CRON |
|---|---|---|
| Price | $10.68 | $3.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 190.0K | ★ 3.2M |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 7.57% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $132,357,000.00 |
| Revenue This Year | N/A | $19.67 |
| Revenue Next Year | N/A | $30.56 |
| P/E Ratio | ★ N/A | $33.56 |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $9.20 | $1.60 |
| 52 Week High | $10.67 | $3.43 |
| Indicator | AWF | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 39.76 | 71.87 |
| Support Level | $10.53 | $2.40 |
| Resistance Level | $10.71 | $3.43 |
| Average True Range (ATR) | 0.06 | 0.18 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 15.56 | 76.70 |
Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.